NewHealth•1h
•1 min readEli Lilly lifts revenue outlook on weight-loss drug sales, trims profit view on deal charges
By Patrick Wingrove Oct 29 (Reuters) Eli Lilly raised its full-year revenue forecast and beat third-quarter earnings expectations on Thursday, propelled by surging demand for injectable weight-loss drugs that could allay investor concerns about price erosion in US government health plans. The...
Continue reading